Human intestinal spirochaetosis is caused by the colonisation of the luminal membrane of the colon and rectum by anaerobic spirochaetes belonging to the genus Brachyspira. The common method used for its diagnosis is routine haematoxylin and eosin staining of colonic and rectal biopsy samples. The clinical spectrum of human intestinal spirochaetosis is heterogeneous, ranging from asymptomatic colonisation to symptoms such as chronic mucosal diarrhoea, rectal bleeding, and abdominal pain. In this Grand Round, we present a detailed report of the endoscopic and histological evaluation and clinical and therapeutic management of an immunocompetent patient with chronic watery diarrhoea caused by intestinal spirochaetosis followed by infection with Giardia lamblia. The initial histological picture mimicked other causes of chronic diarrhoea, such as inflammatory bowel disease, microscopic colitis, and eosinophilic enterocolitis, leading to a delay in diagnosis and treatment. A full course of metronidazole led to the remission of symptoms and to the complete eradication of pathogens as shown by the follow-up histological assessment. This case report highlights the need to consider intestinal spirochaetosis in the differential diagnosis of chronic watery diarrhoea, even when immunodeficiency or other probable risk factors are not present.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(24)00739-4DOI Listing

Publication Analysis

Top Keywords

intestinal spirochaetosis
20
giardia lamblia
8
eosinophilic enterocolitis
8
human intestinal
8
chronic watery
8
watery diarrhoea
8
chronic
5
spirochaetosis
5
chronic intestinal
4
spirochaetosis giardia
4

Similar Publications

Human intestinal spirochaetosis is caused by the colonisation of the luminal membrane of the colon and rectum by anaerobic spirochaetes belonging to the genus Brachyspira. The common method used for its diagnosis is routine haematoxylin and eosin staining of colonic and rectal biopsy samples. The clinical spectrum of human intestinal spirochaetosis is heterogeneous, ranging from asymptomatic colonisation to symptoms such as chronic mucosal diarrhoea, rectal bleeding, and abdominal pain.

View Article and Find Full Text PDF

Objective: This systematic review aimed to explore any demographic, biological and behavioural characteristics of men who have sex with men (MSM) with diarrhoeagenic .

Design/methods: We searched MEDLINE, EMBASE, and CINAHL for manuscripts published to March 2024. One author screened manuscript abstracts; two authors independently conducted a full text review.

View Article and Find Full Text PDF

Coexistence of Intestinal Spirochetosis and Colorectal Cancer: Could the Coil be Carcinogenic?

ACG Case Rep J

November 2024

Division of Gastroenterology, Hepatology, and Nutrition, University of Florida College of Medicine, North Florida/South Georgia Veterans Health System, Gainesville, FL.

Intestinal spirochetosis (IS) is an infectious gastrointestinal disease caused by bacteria. We detail an exceedingly rare case of IS with concomitant invasive colorectal adenocarcinoma (CRC) in a 58-year-old man presenting with abdominal discomfort and fever. Colonoscopic evaluation revealed abnormal-appearing, nodular cecal mucosa and a 35 mm rectosigmoid mass.

View Article and Find Full Text PDF

BPP43_05035 is a cell surface adhesin that weakens the integrity of the epithelial barrier during infection.

Gut Microbes

September 2024

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

The anaerobic spirochete causes intestinal spirochetosis, characterized by the intimate attachment of bacterial cells to the colonic mucosa, potentially leading to symptoms such as diarrhea, abdominal pain, and weight loss. Despite the clinical significance of infections, the mechanism of the interaction between and the colon epithelium is not known. We characterized the molecular mechanism of the -epithelium interaction and its impact on the epithelial barrier during infection.

View Article and Find Full Text PDF
Article Synopsis
  • Leptospirosis is a re-emerging zoonotic disease that affects both humans and animals, often causing intestinal symptoms and highlighting the importance of gut microbiota in immune response and disease resistance.
  • Research indicates that short-chain fatty acids (SCFAs), particularly butyrate, play a protective role against leptospirosis by enhancing immune responses through increased reactive oxygen species (ROS) production.
  • The study presents a potential therapeutic pathway through the butyrate-MCT-HDAC3i-ROS signaling axis, suggesting this could be a target for developing strategies to prevent acute leptospirosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!